Muller & Phipps (Ceylon) PLC

MULL.N0000Overvalued

Consumer & Retail · Wholesale Distributors

Muller & Phipps (Ceylon) PLC is a Sri Lanka-based importer and distributor operating in the healthcare and pharmaceutical sector.

MULL shares are up 65.2% over the past year and last closed at Rs 3.80 on Nov 17, 2026.

Rs 3.80
+0.00%
as of Nov 17, 2026
Price history
+65.22%
P/E
-
P/B
Negative book
NAV / Share
Rs -0.58
EPS
Rs -0.24to Sep 26
Revenue Growth
-12.9%
Div Yield
0.00%
Market Cap
Rs 1.1B
Beta
3.83
ROE
-
Op Margin
2.6% (+3.0pp)

Fundamentals

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue
Rs 587.3M
-19.0%
Rs 724.6M
-5.1%
Rs 763.5M
+44.9%
Rs 526.9M
-50.5%
Rs 1.1B
+41.8%
Rs 750.9M
-11.4%
Rs 847.1M
-14.3%
Rs 988.6M
+5.5%
Operating profit
Rs -49.2M
Rs -56.8M
Rs 87.0M
+11.4%
Rs 78.1M
-34.1%
Rs 118.5M
+63.2%
Rs 72.7M
Rs -25.3M
Rs -2.2M
Net profit
Rs -71.4M
loss narrowed
Rs -83.7M
fell into loss
Rs 75.1M
turned profitable
Rs -88.3M
loss widened
Rs -36.7M
fell into loss
Rs 66.8M
turned profitable
Rs -104.0M
loss widened
Rs -60.5M
fell into loss
EPS
-0.25
-0.30
0.27
-0.31
-0.13
0.24
-0.37
-0.21

Compared with the same period a year earlier.

Per-share figures are as reported, not adjusted for splits.

Ex-dateDividendPer share
-2018Rs 0.05
-2017Rs 0.07
-2014Rs 0.05

Upcoming dividends, rights issues and splits across the CSE: dividend calendar →

Sector comparisonConsumer & Retail · 35 companies
P/E
11.4
P/B
32.05
ROE
282.11%
Yield
8.61%
P/E
15.7
P/B
12.29
ROE
90.67%
Yield
5.15%
P/E
15.7
P/B
4.02
ROE
25.61%
Yield
2.91%
P/E
13.8
P/B
3.32
ROE
26.25%
Yield
4.16%
P/E
15.4
P/B
5.19
ROE
33.72%
Yield
5.53%
P/E
11.2
P/B
3.96
ROE
35.26%
Yield
2.62%
P/E
8.8
P/B
2.05
ROE
23.32%
Yield
3.73%
P/E
47.6
P/B
7.93
ROE
16.67%
Yield
0.00%
MULL.N0000 · this company
P/E
-
P/B
-
ROE
-
Yield
0.00%
Sector median · 35 companies
P/E 14.4P/B 1.73Yield 1.73%

About Muller & Phipps (Ceylon) PLC

Muller & Phipps (Ceylon) PLC is a Sri Lanka-based importer and distributor operating in the healthcare and pharmaceutical sector. The Group distributes pharmaceutical and healthcare products through an ERP-enabled, island-wide network supported by 16 distributors and more than 3,000 customer touchpoints. The Company’s activities include pharmaceutical distribution, marketing and medical engagement, and supply chain management, underpinned by compliance-driven operations and digital sales platforms. During the year the Group expanded into therapeutic nutrition with the introduction of Dreavia Switzerland nutrition products, including Dreavia Rontamil. The Group operates in Sri Lanka and comprises Muller & Phipps (Ceylon) PLC and its wholly owned subsidiary, Muller & Phipps (Health Care) Limited, leveraging distribution, professional engagement, and digital channels to service healthcare professionals, retailers and other customers nationwide.

AI analysis

bearish

Evidence points bearish: September still produced a LKR 3 million net loss while equity attributable to owners was negative. The counterpoint is that the business returned to an operating profit.

Read the full report (Nov 9, 2026) →

News sentiment

Describes news flow, not a forecast
Last 30 days
Not enough news to read

No scored news in the last 30 days.

24 months positive negative 3-month net
Nov 24Mar 25Jul 25Nov 25Mar 26Jul 26

Consumer & Retail sector: what is happening

Last 14 days to Nov 18, 2026

Consumer staples news centred on Budget proposals to exempt printed and exercise books from VAT, remove PAL on newsprint imports and cut CESS rates on selected import lines, reducing costs for print retail. Household spending rose largely with market prices, indicating pressure on real consumption. The IMF highlighted lower excise on imported liquor than domestic alcohol, keeping tax neutrality and border controls in focus for the beverages market.

Auto-generated from 7 sector news articles over 14 days. Not investment advice.